Form D · Biotechnology
EDP Biotech Corp
Knoxville, TN · CIK 0001336446
Offering snapshot reported Aug 6, 2019 · SEC filing
- Reported sold
- Yet to sell Offering amount: $1.5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 6, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 13, 2013 | Initial | $200,000 | No comparison | 3 | SEC filing |
| Dec 17, 2010 | Initial | $705,000 | No comparison | 10 | SEC filing |
| Apr 12, 2010 | Initial | $516,000 | No comparison | 8 | SEC filing |
| Feb 9, 2010 | Initial | $150,000 | No comparison | 2 | SEC filing |
| Jan 14, 2010 | Initial | $1,285,000 | No comparison | 17 | SEC filing |
| Aug 16, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-345907
Source: Form D, filed Aug 6, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| R. Daniel Beauchamp, Md | Executive |
| Randall Deward Boyd | Director |
| Tom Boyd | Director |
| Dr. John J. Costanzi | Executive |
| Herbert Fritsche, Ph D | Director |
| Herbert Ftitsche, Ph D | Executive |
| Kevin David Jones | Executive |
| L. Dean Knoll, M.D. | Director |
| Jon F. Koncak | Director |
| Jason Liggett | Executive |
| Eric Mayer | Executive |
| Olivia Mc Ghee | Executive |
| Bergein Overholt, M.D. | Director |
| Janet Parkey | Executive |
| Jeff Peters | Director |
| Jeffrey D. Peters | Director |
| Meg Retinger | Director |
| Margaret Hathaway Retinger | Executive |
| James Earl Simpson | Executive |
| Michael Spalding | Director |
| Michael J. Spalding, M.D. | Director |
| Walter R. Threlfall Dvm, Ms, Ph D, Act | Executive |
| Doug Yoakley | Director |
| Robin Zimmer | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6701 Baum Drive Suite 110
Knoxville, TN, 37919
Knoxville, TN, 37919